Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Neoplasms | 10 | 2015 | 22 | 2.480 |
Why?
|
| Spinal Cord Neoplasms | 6 | 2013 | 12 | 2.080 |
Why?
|
| Fetal Proteins | 4 | 2016 | 7 | 1.780 |
Why?
|
| T-Box Domain Proteins | 4 | 2016 | 14 | 1.770 |
Why?
|
| Chordoma | 6 | 2016 | 7 | 1.750 |
Why?
|
| Neurosurgical Procedures | 8 | 2018 | 100 | 1.300 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2016 | 10 | 0.930 |
Why?
|
| Thoracic Vertebrae | 3 | 2015 | 44 | 0.810 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2015 | 68 | 0.670 |
Why?
|
| Humans | 46 | 2020 | 32968 | 0.670 |
Why?
|
| Back Pain | 1 | 2020 | 29 | 0.650 |
Why?
|
| Atlanto-Occipital Joint | 2 | 2010 | 4 | 0.640 |
Why?
|
| Cannabinoids | 1 | 2020 | 42 | 0.630 |
Why?
|
| Stereotaxic Techniques | 3 | 2010 | 23 | 0.620 |
Why?
|
| Cervical Vertebrae | 4 | 2015 | 54 | 0.610 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 727 | 0.610 |
Why?
|
| Preoperative Care | 2 | 2011 | 123 | 0.590 |
Why?
|
| Spinal Fusion | 5 | 2014 | 63 | 0.590 |
Why?
|
| Lumbar Vertebrae | 4 | 2019 | 110 | 0.580 |
Why?
|
| Brain Abscess | 1 | 2018 | 4 | 0.570 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2018 | 6 | 0.560 |
Why?
|
| Cell Proliferation | 3 | 2016 | 604 | 0.560 |
Why?
|
| Decompression, Surgical | 3 | 2019 | 56 | 0.550 |
Why?
|
| Hearing Aids | 1 | 2017 | 4 | 0.550 |
Why?
|
| Meningitis, Fungal | 1 | 2017 | 1 | 0.520 |
Why?
|
| Ascomycota | 1 | 2017 | 5 | 0.520 |
Why?
|
| Methylprednisolone | 1 | 2017 | 13 | 0.520 |
Why?
|
| Drug Contamination | 1 | 2017 | 6 | 0.520 |
Why?
|
| Abscess | 1 | 2017 | 27 | 0.510 |
Why?
|
| Liposomes | 1 | 2016 | 30 | 0.500 |
Why?
|
| Communication | 1 | 2017 | 141 | 0.490 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 59 | 0.490 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 113 | 0.480 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 240 | 0.480 |
Why?
|
| Nanoparticles | 1 | 2016 | 56 | 0.470 |
Why?
|
| Monitoring, Intraoperative | 4 | 2009 | 44 | 0.460 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2015 | 2 | 0.450 |
Why?
|
| Chondrosarcoma | 2 | 2014 | 8 | 0.450 |
Why?
|
| Aorta, Thoracic | 1 | 2015 | 85 | 0.430 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2014 | 4 | 0.420 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 36 | 0.420 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 42 | 0.420 |
Why?
|
| Epidermal Cyst | 1 | 2013 | 4 | 0.410 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2014 | 57 | 0.410 |
Why?
|
| Intraoperative Complications | 2 | 2011 | 59 | 0.410 |
Why?
|
| Atlanto-Axial Joint | 2 | 2010 | 4 | 0.410 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2010 | 25 | 0.390 |
Why?
|
| Endoscopy | 2 | 2010 | 56 | 0.390 |
Why?
|
| Vasospasm, Intracranial | 2 | 2010 | 13 | 0.380 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 429 | 0.380 |
Why?
|
| Apoptosis | 1 | 2014 | 363 | 0.360 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 158 | 0.360 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 98 | 0.350 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 1015 | 0.350 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2011 | 1 | 0.350 |
Why?
|
| Medical Errors | 1 | 2011 | 37 | 0.350 |
Why?
|
| Male | 21 | 2019 | 19754 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2014 | 950 | 0.330 |
Why?
|
| Basilar Artery | 1 | 2010 | 9 | 0.330 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2010 | 7 | 0.330 |
Why?
|
| Spinal Cord Compression | 1 | 2010 | 7 | 0.320 |
Why?
|
| Radiosurgery | 2 | 2011 | 362 | 0.320 |
Why?
|
| Orthopedic Procedures | 1 | 2011 | 95 | 0.320 |
Why?
|
| Cervical Atlas | 1 | 2010 | 1 | 0.320 |
Why?
|
| Skull Base | 1 | 2010 | 4 | 0.320 |
Why?
|
| Neurosurgery | 2 | 2018 | 38 | 0.320 |
Why?
|
| Laminectomy | 3 | 2019 | 17 | 0.320 |
Why?
|
| Female | 20 | 2019 | 20375 | 0.320 |
Why?
|
| Glioblastoma | 1 | 2011 | 157 | 0.320 |
Why?
|
| Mouth | 1 | 2010 | 24 | 0.320 |
Why?
|
| Middle Aged | 15 | 2019 | 12203 | 0.320 |
Why?
|
| Occipital Bone | 1 | 2010 | 18 | 0.320 |
Why?
|
| Bone Neoplasms | 1 | 2011 | 117 | 0.310 |
Why?
|
| Neuroendoscopes | 1 | 2009 | 1 | 0.300 |
Why?
|
| Neuroendoscopy | 1 | 2009 | 4 | 0.300 |
Why?
|
| Ependymoma | 1 | 2009 | 4 | 0.300 |
Why?
|
| Joint Instability | 1 | 2010 | 86 | 0.290 |
Why?
|
| Diskectomy | 3 | 2015 | 18 | 0.290 |
Why?
|
| Vertebroplasty | 1 | 2008 | 1 | 0.280 |
Why?
|
| Polymethyl Methacrylate | 1 | 2008 | 12 | 0.280 |
Why?
|
| Aneurysm, Dissecting | 1 | 2008 | 12 | 0.270 |
Why?
|
| Intracranial Aneurysm | 1 | 2008 | 68 | 0.250 |
Why?
|
| Renal Artery Obstruction | 1 | 2006 | 38 | 0.240 |
Why?
|
| Renal Artery | 1 | 2006 | 47 | 0.240 |
Why?
|
| Abdominal Injuries | 1 | 2006 | 31 | 0.240 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 457 | 0.240 |
Why?
|
| Gliosarcoma | 1 | 2005 | 1 | 0.240 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2006 | 87 | 0.230 |
Why?
|
| Postoperative Complications | 5 | 2015 | 828 | 0.230 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 193 | 0.230 |
Why?
|
| Stents | 1 | 2006 | 174 | 0.220 |
Why?
|
| Aged | 12 | 2019 | 10637 | 0.220 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 105 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2010 | 647 | 0.210 |
Why?
|
| Sacrum | 2 | 2014 | 21 | 0.190 |
Why?
|
| Spinal Diseases | 2 | 2014 | 23 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2015 | 1310 | 0.190 |
Why?
|
| Combined Modality Therapy | 3 | 2015 | 563 | 0.180 |
Why?
|
| Treatment Outcome | 6 | 2013 | 3460 | 0.180 |
Why?
|
| Hematoma, Subdural | 2 | 2013 | 12 | 0.180 |
Why?
|
| Sarcoma | 2 | 2014 | 71 | 0.180 |
Why?
|
| Signal Transduction | 2 | 2016 | 689 | 0.180 |
Why?
|
| Adult | 7 | 2018 | 9586 | 0.170 |
Why?
|
| Child | 4 | 2013 | 2478 | 0.170 |
Why?
|
| Craniotomy | 2 | 2012 | 46 | 0.160 |
Why?
|
| Radiculopathy | 1 | 2019 | 6 | 0.150 |
Why?
|
| Brain | 2 | 2006 | 949 | 0.150 |
Why?
|
| Spinal Stenosis | 1 | 2019 | 10 | 0.150 |
Why?
|
| Spinal Cord | 2 | 2009 | 121 | 0.140 |
Why?
|
| Spinal Cord Injuries | 2 | 2015 | 40 | 0.130 |
Why?
|
| Hearing Loss | 1 | 2017 | 26 | 0.130 |
Why?
|
| Amphotericin B | 1 | 2017 | 12 | 0.130 |
Why?
|
| Angiography | 2 | 2008 | 80 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 2017 | 41 | 0.130 |
Why?
|
| Animals | 6 | 2011 | 7599 | 0.130 |
Why?
|
| Protamines | 1 | 2016 | 4 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 65 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2017 | 308 | 0.120 |
Why?
|
| Recurrence | 1 | 2017 | 282 | 0.120 |
Why?
|
| Pneumocephalus | 1 | 2015 | 3 | 0.120 |
Why?
|
| Esophageal Perforation | 1 | 2015 | 2 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 4065 | 0.120 |
Why?
|
| DNA | 1 | 2016 | 219 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2015 | 28 | 0.110 |
Why?
|
| Rats | 2 | 2011 | 1610 | 0.110 |
Why?
|
| Polymers | 2 | 2005 | 66 | 0.110 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 80 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 2287 | 0.110 |
Why?
|
| Hemipelvectomy | 1 | 2014 | 1 | 0.110 |
Why?
|
| Rhabdomyosarcoma | 1 | 2014 | 6 | 0.110 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2014 | 5 | 0.110 |
Why?
|
| Anticoagulants | 2 | 2013 | 136 | 0.110 |
Why?
|
| Neuronavigation | 1 | 2014 | 8 | 0.110 |
Why?
|
| Accidents, Traffic | 2 | 2014 | 197 | 0.110 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2014 | 17 | 0.100 |
Why?
|
| Manikins | 1 | 2014 | 39 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 91 | 0.100 |
Why?
|
| Bone Screws | 1 | 2014 | 63 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 255 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2014 | 226 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2014 | 115 | 0.100 |
Why?
|
| Random Allocation | 2 | 2011 | 229 | 0.100 |
Why?
|
| Thromboembolism | 1 | 2013 | 38 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 290 | 0.100 |
Why?
|
| Cell Movement | 1 | 2014 | 173 | 0.100 |
Why?
|
| Adolescent | 3 | 2010 | 3643 | 0.100 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 50 | 0.100 |
Why?
|
| Hematoma, Subdural, Chronic | 1 | 2012 | 3 | 0.090 |
Why?
|
| Young Adult | 4 | 2015 | 2738 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2014 | 500 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 72 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2014 | 821 | 0.090 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2011 | 7 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 39 | 0.090 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2011 | 4 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 122 | 0.090 |
Why?
|
| Sciatic Neuropathy | 1 | 2011 | 15 | 0.080 |
Why?
|
| Glioma | 1 | 2012 | 136 | 0.080 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2010 | 11 | 0.080 |
Why?
|
| Tibia | 1 | 2011 | 60 | 0.080 |
Why?
|
| Cell Survival | 1 | 2011 | 281 | 0.080 |
Why?
|
| Retropharyngeal Abscess | 1 | 2010 | 2 | 0.080 |
Why?
|
| Odontoid Process | 1 | 2010 | 2 | 0.080 |
Why?
|
| Internal Fixators | 1 | 2010 | 7 | 0.080 |
Why?
|
| Cerebral Angiography | 1 | 2010 | 60 | 0.080 |
Why?
|
| Injections, Intraventricular | 2 | 2011 | 13 | 0.080 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2010 | 2 | 0.080 |
Why?
|
| Pharynx | 1 | 2010 | 14 | 0.080 |
Why?
|
| Multiple Trauma | 1 | 2010 | 41 | 0.080 |
Why?
|
| Gene Expression | 1 | 2011 | 336 | 0.080 |
Why?
|
| Brachial Plexus | 1 | 2010 | 26 | 0.080 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2009 | 1 | 0.080 |
Why?
|
| Neoplasms, Bone Tissue | 1 | 2009 | 1 | 0.080 |
Why?
|
| Neoplasms, Plasma Cell | 1 | 2009 | 1 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2010 | 78 | 0.080 |
Why?
|
| Giant Cell Tumors | 1 | 2009 | 4 | 0.080 |
Why?
|
| Carcinoma | 1 | 2010 | 92 | 0.080 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2009 | 7 | 0.080 |
Why?
|
| Hemangioma | 1 | 2009 | 22 | 0.080 |
Why?
|
| Epidural Abscess | 1 | 2009 | 5 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 57 | 0.070 |
Why?
|
| Radiography | 1 | 2010 | 386 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2009 | 61 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 73 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2009 | 43 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2009 | 78 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2009 | 95 | 0.070 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 82 | 0.070 |
Why?
|
| Delayed-Action Preparations | 2 | 2006 | 36 | 0.070 |
Why?
|
| Disease Management | 1 | 2009 | 128 | 0.070 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2008 | 3 | 0.070 |
Why?
|
| Bone Cements | 1 | 2008 | 11 | 0.070 |
Why?
|
| Radiographic Image Enhancement | 1 | 2008 | 27 | 0.070 |
Why?
|
| Fluoroscopy | 1 | 2008 | 39 | 0.070 |
Why?
|
| Microsurgery | 1 | 2008 | 21 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2014 | 3708 | 0.070 |
Why?
|
| Cerebral Hemorrhage | 1 | 2008 | 70 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 300 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 69 | 0.060 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2006 | 1 | 0.060 |
Why?
|
| Polyvinyls | 1 | 2006 | 7 | 0.060 |
Why?
|
| Intracranial Embolism | 1 | 2006 | 14 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 412 | 0.060 |
Why?
|
| Cerebral Infarction | 1 | 2006 | 22 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2010 | 1282 | 0.060 |
Why?
|
| Heart Valve Diseases | 1 | 2006 | 29 | 0.060 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 24 | 0.060 |
Why?
|
| Intracranial Hemorrhages | 1 | 2006 | 33 | 0.060 |
Why?
|
| Hematoma | 1 | 2006 | 27 | 0.060 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2006 | 41 | 0.060 |
Why?
|
| Fibrinolytic Agents | 1 | 2006 | 69 | 0.060 |
Why?
|
| Injections, Intralesional | 1 | 2005 | 14 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 64 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2005 | 33 | 0.060 |
Why?
|
| Microspheres | 1 | 2005 | 44 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 160 | 0.060 |
Why?
|
| Mice | 1 | 2011 | 2529 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 134 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 476 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2006 | 148 | 0.060 |
Why?
|
| Doxorubicin | 1 | 2005 | 84 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2004 | 8 | 0.060 |
Why?
|
| Anesthesia, Conduction | 1 | 2004 | 24 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 754 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2004 | 33 | 0.050 |
Why?
|
| Rabbits | 3 | 2011 | 193 | 0.050 |
Why?
|
| Survival Rate | 1 | 2005 | 895 | 0.050 |
Why?
|
| Stroke | 1 | 2008 | 610 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 308 | 0.050 |
Why?
|
| Range of Motion, Articular | 2 | 2014 | 195 | 0.050 |
Why?
|
| Prognosis | 1 | 2006 | 1547 | 0.050 |
Why?
|
| Atrophy | 2 | 2012 | 46 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2004 | 370 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 527 | 0.040 |
Why?
|
| Length of Stay | 2 | 2012 | 329 | 0.040 |
Why?
|
| Leg | 1 | 2019 | 65 | 0.040 |
Why?
|
| Low Back Pain | 1 | 2019 | 47 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2019 | 156 | 0.040 |
Why?
|
| Developing Countries | 1 | 2018 | 57 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2019 | 467 | 0.030 |
Why?
|
| Reoperation | 1 | 2019 | 260 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2019 | 356 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2014 | 1581 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 684 | 0.030 |
Why?
|
| Pain | 1 | 2019 | 296 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 253 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 82 | 0.030 |
Why?
|
| Automobiles | 1 | 2014 | 15 | 0.030 |
Why?
|
| Air Bags | 1 | 2014 | 15 | 0.030 |
Why?
|
| Arthroplasty | 1 | 2014 | 29 | 0.030 |
Why?
|
| Neck | 1 | 2014 | 31 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 97 | 0.030 |
Why?
|
| Enoxaparin | 1 | 2013 | 21 | 0.030 |
Why?
|
| Warfarin | 1 | 2013 | 34 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 134 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 101 | 0.020 |
Why?
|
| Aspirin | 1 | 2013 | 62 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2013 | 85 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2012 | 28 | 0.020 |
Why?
|
| Pressure | 1 | 2012 | 51 | 0.020 |
Why?
|
| Rotation | 1 | 2012 | 52 | 0.020 |
Why?
|
| Drainage | 1 | 2012 | 64 | 0.020 |
Why?
|
| Sacrococcygeal Region | 1 | 2011 | 6 | 0.020 |
Why?
|
| Cadaver | 1 | 2012 | 165 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2013 | 205 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2011 | 11 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2012 | 58 | 0.020 |
Why?
|
| Cisterna Magna | 1 | 2011 | 1 | 0.020 |
Why?
|
| Survival | 1 | 2011 | 12 | 0.020 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2011 | 18 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 63 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2011 | 108 | 0.020 |
Why?
|
| Osteotomy | 1 | 2011 | 57 | 0.020 |
Why?
|
| Tibial Nerve | 1 | 2011 | 21 | 0.020 |
Why?
|
| Anesthesia | 1 | 2011 | 64 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 436 | 0.020 |
Why?
|
| Sural Nerve | 1 | 2011 | 27 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 118 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 245 | 0.020 |
Why?
|
| Executive Function | 1 | 2010 | 57 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2010 | 111 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 74 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2010 | 92 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2009 | 12 | 0.020 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2011 | 198 | 0.020 |
Why?
|
| Ventriculostomy | 1 | 2009 | 11 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2009 | 43 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2009 | 26 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2011 | 351 | 0.020 |
Why?
|
| Registries | 1 | 2010 | 320 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2010 | 162 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 537 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1083 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2006 | 13 | 0.020 |
Why?
|
| Cerebral Veins | 1 | 2006 | 11 | 0.020 |
Why?
|
| Heart Valves | 1 | 2006 | 16 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 381 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2006 | 10 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2006 | 16 | 0.020 |
Why?
|
| Intracranial Hypertension | 1 | 2006 | 19 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2006 | 64 | 0.020 |
Why?
|
| Echocardiography | 1 | 2006 | 191 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 4001 | 0.010 |
Why?
|
| Drug Implants | 1 | 2004 | 11 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 271 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 99 | 0.010 |
Why?
|
| Analgesia, Epidural | 1 | 2004 | 50 | 0.010 |
Why?
|
| United States | 1 | 2010 | 4132 | 0.010 |
Why?
|